Current through Register Vol. 47, No. 17, September 10, 2024
Basis and Purpose - 5020
The statutory authority for this rule includes but is not
limited to sections
44-50-202(1)(b),
44-50-203(1)(b),
44-50-203(1)(g),
44-50-203(1)(j),
44-50-203(2)(e),
44-50-203(2)(g),
44-50-203(2)(h),
44-50-203(2)(i),
44-50-203(2)(j),
44-50-203(2)(k),
44-50-203(2)(p),
C.R.S. The purpose of this rule is to establish health and sanitation
requirements for Natural Medicine Cultivation Facilities and the equipment used
at Natural Medicine Cultivation Facilities, record requirements, waste and
destruction requirements for contaminated Natural Medicine, and storage,
packaging and labeling requirements.
A.
Regulated Natural Medicine must be produced in a sanitary environment, where
all surfaces are maintained and kept in a clean manner.
1. Filters for air conditioning, ventilation,
and air filtration systems must be cleaned and replaced regularly. Overhead
light fixtures must be reasonably free of dust and insects.
2. Water must be potable. If well water is
used, wells must be maintained to protect them from contamination. Floors must
drain adequately, and there shall not be standing water on the floor of the
Licensed Premises.
B.
Cultivation Activities - Premises and Safety
Requirements.
1. Toxic cleaning
compounds, sanitizing agents, and other chemicals shall be identified, held,
stored, and disposed of in a manner that protects against contamination of
Regulated Natural Medicine, and in accordance with any applicable local, state,
or federal law, rule, regulation, or ordinance. The use of any of the above
compounds must be tracked in the safety data sheet, which must be kept in
accordance with Rule 3010.
2.
Ambient oxygen and CO2 monitors with alarms for elevated
CO2 levels (>1000 ppm) must be used in any fruiting
rooms. CO2 monitors should be placed at eye
level.
3. All individuals working
in direct contact with Regulated Natural Medicine in open-air cultivation rooms
must have access to appropriate respiratory protection equipment to prevent
mushroom worker's lung.
4. The
movement of employees between growing areas and substrate production areas must
be controlled to prevent contamination.
5. Any receiving areas for raw materials or
substrate must be located away from areas where harvest containers, packaging
materials, spores, and other sanitary supplies are received. This includes
where Regulated Natural Medicine is located.
C.
Equipment.
Equipment must be maintained to prevent contamination.
1. Equipment must be maintained to ensure it
is in proper working order and does not contribute to contamination. All
lubricants used on machinery with direct or indirect food contact and all
processing aids must be food grade.
2. Suppliers of baskets, lugs, trays, tills
and boxes must provide documentation that the material purchased is approved by
the FDA for food contact surfaces.
a. Harvest
baskets, lugs, and trays must be cleaned and sanitized before use or stored,
and maintained to prevent splinters or shards. Containers with Regulated
Natural Medicine must be clearly marked for this purpose and not be used for
any other purpose
3.
Temperature probes and supporting hardware to monitor growing conditions must
be monitored and calibrated on a regular basis. Only non-mercury thermometers
are allowed.
4.
Cultivation Equipment. All harvesting equipment must
be cleaned and sanitized prior to harvesting, and on a scheduled basis.
a. Baskets, lugs, trays and boxes used for
harvesting must not contact the floor. Any filled harvest containers must be
moved from growing rooms to staging areas in order to not contact the floor. If
any Regulated Natural Medicine comes in contact with the floor, it must be
discarded.
b. Once Regulated
Natural Medicine is harvested, it must be placed in a container that is
protected from materials that could fall into it.
D.
Cultivation
materials.
1. Cultivation
materials, ingredients, and Regulated Natural Medicine that can support the
rapid growth of undesirable microorganisms must be stored in a manner that
prevents the growth of these microorganisms.
2.
Substrate
Preparation. Any unpasteurized substrate and storage areas must be
adequately separated from areas where pasteurized substrate is stored to
prevent cross-contamination.
a. Appropriate
measures must be in place to prevent any seepage or runoff from the
unpasteurized substrate preparation area by collecting or diverting it from the
pasteurized substrate area.
E.
Records. All
records must be kept on file in accordance with Rule 3010.
1. If a Natural Medicine Cultivation Facility
uses raw materials in the production of Regulated Natural Medicine, the
Licensee must obtain and maintain documentation of the substrate, compost or
other cultivation materials purchased, including the date of
purchase.
2.
Standard
Operating Procedures (SOP). A Natural Medicine Cultivation
Facility must have standard operating procedures for each method of cultivation
on file, and available upon request for inspection by the Division. The SOP
must include:
a. A documented Regulated
Natural Medicine safety plan, including worker training on proper Regulated
Natural Medicine handling, hand washing, hair restraint, and use of
gloves.
b.
Handling of
Chemicals. Written procedures must document how workers are
trained on the proper use of chemicals, and containers used to store chemical
solutions are clearly marked with the common name of the chemical, and
instructions for proper use, and non-food containers are used to prepare and
hold all chemical solutions.
c.
Pest Control. Written procedures must document pest
control strategies. All pest control devices must be located away from products
so as to avoid contamination. At least one pest control device should be within
10 feet of each side of an outside entrance. If used, poison bait stations are
used exclusively on the outside of the building. If used, all live traps are
placed a maximum of 30 feet apart and at entrances. If pest lights are used,
they must be placed so as to not attract pests into the building. All pest
control devices are located on a map.
d.
Cultivation Materials and
Procedures. Written documentation of materials used to cultivate
Regulated Natural Medicine, including any equipment, ingredients, substrate,
raw materials, spore type, and any additives.
e.
Instructions for Cultivation
and Sampling. Specific instructions detailing each step in the
cultivation process, including the expected yield of the cultivation. Written
sampling procedures including Sample collection and test submission
steps.
3.
Corrective Action Preventative Action. A Natural
Medicine Cultivation Facility shall establish and maintain written procedures
for implementing corrective action and preventive action (CAPA). The written
procedures shall include the requirements listed below as determined by the
Licensee. All activities required under this Rule, and their results, shall be
documented and kept as business records. The written procedures shall include
requirements, as appropriate, for:
a. What
constitutes a Nonconformance in the Licensee's business operation;
b. Analyzing processes, work operations,
reports, records, service records, complaints, returned product, and/or other
sources of data to identify existing and potential root causes of
Nonconformances or other quality problems;
c. Investigating the root cause of
Nonconformances relating to product, processes, and the quality
system;
d. Identifying the
action(s) needed to correct and prevent recurrence of Nonconformance and other
quality problems;
e. Verifying the
CAPA to ensure that such action is effective and does not adversely affect
finished products;
f. Implementing
and recording changes in methods and procedures needed to correct and prevent
identified quality problems;
g.
Ensuring the information related to quality problems or Nonconformances is
disseminated to those directly responsible for assuring the quality of products
or the prevention of such problems; and
h. Submitting relevant information on
identified quality problems and CAPA documentation, and confirming the result
of the evaluation, for management review.
4. Any Adverse Health Events required to be
reported in Rule 3015.
5.
Certificates of Analysis. All certificates of analysis
provided to the Natural Medicine Cultivation Facility by a Natural Medicine
Testing Facility for any Samples submitted for testing shall be maintained on
the Licensed Premises in accordance with Rule 3010.
F.
Contaminated Regulated Natural
Medicine.
1. If a Sample that was
submitted for testing is contaminated or adulterated, the Harvest Lot must be
disposed of according to Rule 3120.
2. If any Regulated Natural Medicine is
exposed to blood or bodily fluids or is found to contain filth or foreign
matter, it must be disposed of according to Rule 3120.
G.
Directed Testing.
A Natural Medicine Cultivation Facility Licensee shall, upon the Division's
direction, submit a sufficient quantity of Regulated Natural Medicine to a
Natural Medicine Testing Facility for laboratory or chemical analysis in
accordance with Rule 4020. The Division will notify the Licensee of the results
of the analysis.
H.
Storage, Packaging, and Labeling.
1.
Storage. After
cultivation, Regulated Natural Medicine should follow best practices for
storage prior to packaging. Current best practices for the storage of
psilocybin-containing products are to store them at room temperature in
darkness and away from moisture or with devices to absorb moisture to improve
the stability of the active ingredients in the products.
2.
Packaging. All
Regulated Natural Medicine must be packaged in accordance with Rule
3305.
3.
Labeling. All Regulated Natural Medicine must be
labeled in accordance with Rule 3305.
a. A
Natural Medicine Cultivation Facility may establish an expiration date upon
which the Regulated Natural Medicine's Total Psilocin will differ by an amount
greater than +/- fifteen percent from the original test results.
b. The Licensee shall determine the
expiration date by conducting the required testing pursuant to Rule 4010 on the
Regulated Natural Medicine to ensure the Regulated Natural Medicine can pass
tryptamine content and contaminant testing through the established expiration
date.
c. When determining the
expiration date pursuant to this Rule, the Licensee shall also consider the
ideal storage conditions for the Regulated Natural Medicine.
d. Expiration date determinations, along with
any data used to establish the expiration date, such as test results, shall be
documented and maintained in the Licensee's records pursuant to these Part 5
Rules and Rule 3010.
I.
Internal Audit.
Natural Medicine Cultivation Facilities must conduct an annual internal audit
to assess that they are in substantial compliance with the requirements of this
Rule 5020. A copy of the internal audit shall be retained as business records
for one year.